Drugs and Devices

FDA approves device for preventing recurrent strokes in some patients

On Oct. 28, the Food and Drug Administration (FDA) approved the Amplatzer PFO Occluder device, which reduces the risk of a stroke in patients who previously had a stroke believed to be caused by a blood clot passing through a patent foramen ovale and then travelling to the brain. Read more


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares